Cancer Research

Hyaluronic acid-decorated carriers target the CD44 receptor, which is frequently overexpressed in bladder tumors, to improve the specificity of localized therapy. The staggering incidence of urologic malignancies, which currently accounts for more than 2.6 million new cases and 700,000 deaths

Safety profiles for minibeam radiation show significantly fewer skin injuries and hair loss compared to the side effects observed with traditional wide-field radiation techniques. This clinical advantage marks a pivotal shift in managing primary central nervous system lymphoma, a notoriously

The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long limited the reach of personalized autologous cellular treatments in oncology clinics. While chimeric antigen receptor (CAR) T-cell therapies have established a foundational success in treating

The diagnostic reality for nearly ten percent of patients with advanced solid tumors involves a debilitating accumulation of abdominal fluid that traditionally signals the final, most resistant stage of oncological progression. For years, this fluid, known as malignant ascites, was treated

Transcriptomic profiling reveals that suppressing β-catenin in specific mutant cells leads to an overwhelming accumulation of ubiquitinated proteins and cellular stress. This biological response marks a turning point in the treatment of advanced endometrial cancer, which remains a leading cause of

Computational science and digital platforms are being leveraged to bridge the gap between active cancer treatment and the often-neglected survivorship phase. This shift represents a fundamental evolution in oncology, moving away from episodic, clinic-based interactions toward a more fluid and